Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Volume 59, Issue 5, 2016, Pages 578-583
Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany [Aktuelle Seroprävalenz, Impfstatus und prädiktiver Wert der Leberenzyme für Hepatitis B bei Flüchtlingen in Deutschland] (Article)
Hampel A. ,
Solbach P. ,
Cornberg M. ,
Schmidt R.E. ,
Behrens G.M.N. ,
Jablonka A.*
-
a
Klinik für Anästhesie, Notfallmedizin, Operative Intensivmedizin und Schmerztherapie, Klinikum Wolfsburg, Wolfsburg, Germany
-
b
Klinik für Gastroenterologie, Hepatologie, Endokrinologie, Medizinische Hochschule Hannover, Hannover, Germany, Standort Hannover-Braunschweig, Deutsches Zentrum für Infektionsforschung (DZIF), Braunschweig, Germany
-
c
Klinik für Gastroenterologie, Hepatologie, Endokrinologie, Medizinische Hochschule Hannover, Hannover, Germany, Standort Hannover-Braunschweig, Deutsches Zentrum für Infektionsforschung (DZIF), Braunschweig, Germany
-
d
Klinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, Hannover, 30625, Germany, Standort Hannover-Braunschweig, Deutsches Zentrum für Infektionsforschung (DZIF), Braunschweig, Germany
-
e
Klinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, Hannover, 30625, Germany, Standort Hannover-Braunschweig, Deutsches Zentrum für Infektionsforschung (DZIF), Braunschweig, Germany
-
f
Klinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, Hannover, 30625, Germany, Standort Hannover-Braunschweig, Deutsches Zentrum für Infektionsforschung (DZIF), Braunschweig, Germany
Abstract
Background: Currently only vague estimates exist for the seroprevalence and vaccination status for viral hepatitis B (HBV) in refugees arriving in Germany during the current refugee crisis. Objectives: To assess the prevalence of hepatitis B in refugees arriving in northern Germany in 2015. Methods: In a cross-sectional study in 793 patients from all age groups tests for serological markers of hepatitis Bvirus infection (HBsAg, anti-HBc) and liver enzymes (ALT, AST, bilirubin, γGT, alkaline phosphatase) were performed inAugust 2015 at six reception centers in northern Germany. In 258 patients anti-HBs antibodies were assessed additionally. Results: Of the tested refugees, 76.7 % were male, the median age was 28.8 ± 11.4 years, and 7.8 % were children under the age of 18. The overall prevalence of HBsAg and total anti-HBc was 2.3 % and 14.0 % respectively (2.5 % and 14.5 % in men; 1.2 % and 13.5 % in women). Prevalence was highest in 35 to 49-year-old patients for HBsAg (3.1 %) and for refugees over 50 years for anti-HBc (38 %). No immunity to Hepatitis B was found in 62 %, 18.6 % had been vaccinated against Hepatitis B, while 50 % of children aged up to 15 years (n = 12) had been vaccinated. Positive predictive values of elevated AST and ALT for detection of HBsAg was 0 and 0.016, respectively. Only two patients with a positive HBsAg had elevated transaminases. Conclusions: This study showed a high prevalence of HBsAg in a German refugee sample in comparison to the general German population. Liver enzymes are not an appropriate tool for screening for hepatitis B virus infection. © 2016, Springer-Verlag Berlin Heidelberg.
Author Keywords
Index Keywords
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964325366&doi=10.1007%2fs00103-016-2333-8&partnerID=40&md5=1b62c2c2a9e35852ff0852a1b90c8098
DOI: 10.1007/s00103-016-2333-8
ISSN: 14369990
Cited by: 14
Original Language: German